Explore 3 Stock Ideas & Industry Insights Download Free Report

Alcidion Group Ltd

Healthcare AU ALC

0.1AUD
0.00(0%)

Last update at 2026-06-15T06:10:00Z

Day Range

0.100.10
LowHigh

52 Week Range

0.080.14
LowHigh

Fundamentals

  • Previous Close 0.10
  • Market Cap137.71M
  • Volume457326
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA5.87M
  • Revenue TTM48.62M
  • Revenue Per Share TTM0.04
  • Gross Profit TTM 41.64M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 0.32M -8.69900M -4.74000M -3.90800M -0.93400M
Minority interest - - - - -
Net income 1.65M -8.41700M -3.61700M -4.41200M -2.24400M
Selling general administrative 1.09M 28.27M 28.30M 22.39M 17.36M
Selling and marketing expenses 0.74M 0.93M 0.84M 0.58M 0.57M
Gross profit 35.99M 31.92M 1.25M 3.29M 3.52M
Reconciled depreciation - 4.10M 3.19M 2.26M 0.46M
Ebit -0.56400M -8.59600M -4.61500M -3.84000M -0.93100M
Ebitda 1.94M -4.49600M -1.42800M -1.58400M -0.47400M
Depreciation and amortization 2.50M 4.10M 3.19M 2.26M 0.46M
Non operating income net other - - - - -
Operating income 7.81M -7.64600M -4.72600M -1.72800M -0.17400M
Other operating expenses 32.98M 44.70M 45.13M 36.08M 26.06M
Interest expense 1.00M 0.10M 0.12M 0.07M 0.00300M
Tax provision -1.33400M -0.28200M -1.12300M 0.50M 1.31M
Interest income - 0.08M 0.11M 0.02M 0.01M
Net interest income - -0.02000M -0.01400M -0.04400M 0.00900M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 1.33M -0.28200M -1.12300M 0.50M 1.31M
Total revenue 40.79M 37.06M 40.40M 34.35M 25.88M
Total operating expenses 28.18M 31.26M 5.98M 5.02M 3.69M
Cost of revenue 4.80M 5.14M 39.15M 31.06M 22.36M
Total other income expense net -7.48700M -1.05300M -0.01400M -2.18000M -0.76000M
Discontinued operations - - - - -
Net income from continuing ops - -8.41700M -3.61700M -4.41200M -2.24400M
Net income applicable to common shares 1.65M -8.41700M -3.61700M -4.41200M -2.24400M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 115.63M 114.46M 120.68M 128.35M 58.38M
Intangible assets 22.59M - 29.07M 31.06M 2.03M
Earning assets - - - - -
Other current assets 2.31M 1.53M 1.60M 1.67M 1.21M
Total liab 27.82M 27.52M 30.52M 34.40M 13.16M
Total stockholder equity 87.80M 86.94M 90.17M 93.95M 45.22M
Deferred long term liab - - - - -
Other current liab 19.54M 5.38M 6.84M 9.22M 4.96M
Common stock 115.52M 115.52M 110.51M 110.51M 58.57M
Capital stock - - 110.51M 110.51M 58.57M
Retained earnings -28.36600M -30.02000M -21.60300M -17.98600M -13.57400M
Other liab - - 7.78M 8.14M 0.15M
Good will 67.76M 67.76M 67.76M 67.76M 25.46M
Other assets - 0.00000M - - 0.00000M
Cash 17.70M 11.80M 14.64M 17.34M 25.03M
Cash and equivalents - - - - -
Total current liabilities 20.86M 19.21M 21.27M 24.39M 13.00M
Current deferred revenue - 12.83M 11.61M 12.91M 7.11M
Net debt -16.29200M -10.10300M -12.48600M -14.85500M -24.84600M
Short term debt 0.71M 0.70M 0.69M 0.62M 0.16M
Short long term debt - - - - -
Short long term debt total 1.41M 1.70M 2.15M 2.48M 0.18M
Other stockholder equity - - 0.32M 1.43M 0.23M
Property plant equipment - - 2.87M 3.27M 0.55M
Total current assets 23.69M 18.54M 20.98M 26.26M 30.35M
Long term investments - - - - -
Net tangible assets - - -6.66800M -4.86900M 17.73M
Short term investments - - - - -
Net receivables 3.68M 5.21M 4.74M 7.25M 4.11M
Long term debt - - - - -
Inventory - - - - -
Accounts payable 0.62M 0.30M 2.13M 1.65M 0.77M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.65M 1.45M 1.26M 1.43M 0.23M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 26.19M - -0.00200M -
Deferred long term asset charges - - - - -
Non current assets total 91.94M 95.92M 99.71M 102.09M 28.04M
Capital lease obligations - - 2.15M 2.48M 0.18M
Long term debt total - - 1.46M 1.87M 0.02M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments - -0.05300M -3.14100M -59.74300M -9.84300M
Change to liabilities - - -1.71200M 4.27M 2.92M
Total cashflows from investing activities -0.12500M -0.05300M -3.14100M -59.74300M -9.84300M
Net borrowings - - -0.61600M -0.60900M -0.27000M
Total cash from financing activities -0.76400M 4.34M -0.61600M 51.33M 17.23M
Change to operating activities - - 0.54M -0.52800M -0.85500M
Net income 1.65M -8.41700M -3.61700M -4.41200M -2.24400M
Change in cash 5.90M -2.84300M -2.69800M -7.68800M 9.08M
Begin period cash flow 11.80M 14.64M 17.34M 25.03M 15.95M
End period cash flow 17.70M 11.80M 14.64M 17.34M 25.03M
Total cash from operating activities 5.76M -7.12900M 0.17M -2.15600M 1.54M
Issuance of capital stock - 5.40M - 51.94M 17.50M
Depreciation 4.59M 4.10M 1.81M 2.26M 0.46M
Other cashflows from investing activities - 0.00000M -2.68700M -59.43200M -9.53000M
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables 0.80M -0.47900M 2.52M -1.30200M 1.03M
Sale purchase of stock 0.00000M -0.39900M 0.00000M 51.94M 17.50M
Other cashflows from financing activities 0.00000M -0.66200M -0.61600M -0.60900M -0.27000M
Change to netincome - - -0.36800M 0.33M 0.23M
Capital expenditures 0.12M 0.05M 0.45M 0.31M 0.31M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.63M -1.06300M 0.11M 0.02M 0.01M
Stock based compensation 0.13M 0.15M - - -
Other non cash items -1.24800M -1.90100M - 2.16M 1.79M
Free cash flow 5.64M -7.18200M -0.28500M -2.46700M 1.23M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ALC
Alcidion Group Ltd
- -% 0.10 - 66.67 2.83 1.50 3.02 14.14
PME
Pro Medicus Ltd
0.55 0.34% 164.55 71.81 94.34 70.17 44.53 71.10 91.89
EIQ
Echoiq Ltd
0.03 2.61% 1.18 - - 8614.35 45.35 8491.02 -8.2701
AYA
ARTRYA Ltd
0.21 4.67% 4.71 - - 26239.56 8.64 8386.02 0.33
CGS
Cogstate Ltd
0.06 2.19% 2.80 30.11 24.10 8.45 6.01 5.16 16.06

Reports Covered

Stock Research & News

Profile

Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. It offers Miya Precision, a fast healthcare interoperability resource (FHIR)-events platform that integrates digital patient care services, such as a clinical decision support system, electronic patient record (EPR), and patient administration systems (PAS). The company platform also provides electronic patient flow journey boards; virtual care and remote patient management; integrated care system smart operations center; emergency department and specialized care; real-time data integration, FHIR-based interoperability, and predictive analytics; modern modular EPR; and streamlined clinical workflows, intelligent comms, and mobility solutions. In addition, the company offers Smartpage, a smartphone and web-based system for hospital communication and task management; and product implementation, product support and maintenance, systems integration, and data analysis services. The company was formerly known as Alcidion Corporation Pty Ltd and changed its name to Alcidion Group Limited in December 2015. Alcidion Group Limited was founded in 2000 and is headquartered in South Yarra, Australia.

Alcidion Group Ltd

9 Yarra Street, South Yarra, VIC, Australia, 3141

Key Executives

Name Title Year Born
Ms. Kate Quirke MD, CEO & Exec. Director NA
Mr. Matthew Gepp Chief Financial Officer NA
Mr. Colin Bruce MacKinnon Chief Operating Officer NA
Mr. Vivek Krishnan Chief Technology Officer NA
Kerstin Wahlqvist Investor Relations Mang. NA
Ms. Maria Hunter Group Gen. Counsel NA
Ms. Tracey Harvey HR Mang. NA
Ms. Lynette Ousby UK Managing Director NA
Ms. Amanda James Chief People Officer NA
Ms. Julia Stevens Chief of Staff NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.